Science news and articles on health, environment, global warming, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries in astronomy, anthropology, biology, chemistry, climate & bioengineering, computers, engineering ; medicine, math, physics, psychology, technology, and more from the world's leading research centers universities.

ILCregs play an important role in regulation of intestinal inflammation


Credit: Image by IBP

The intestine contains an extensive and diverse microbial flora, including potential pathogens and dietary antigens that needs to be tolerated. Dysregulation of mucosal responses may cause a loss of tolerance, leading to harmful intestinal inflammation such as human inflammatory bowel disease (IBD).

Innate lymphoid cells (ILCs) are located in mucosal surfaces to potentiate immune responses, sustain mucosal integrity and promote lymphoid organogenesis. Three subsets of ILCs have been defined to date and produce substantial effector cytokines upon harmful stress. These ILCs play critical roles in the regulation of type 1, type 2, and type 3 (or Th17 cell) responses, controlling host protective immunity and intestinal homeostasis.

Researchers from FAN Zusen's group at the Institute of Biophysics (IBP) of the Chinese Academy of Sciences have identified a regulatory subpopulation of ILCs (called ILCregs) that exist in the gut and harbor a unique genetic identity distinct from ILCs or regulatory T cells (Tregs).

During inflammatory stimulation, ILCregs can be induced in the intestine and suppress the activation of ILC1s and ILC3s via secretion of IL-10, leading to protection against innate intestinal inflammation.

In addition, TGF-ß1 is consequently secreted by ILCregs upon intestinal inflammation, and autocrine TGF-ß1 sustains the maintenance and increase of ILCregs. Therefore, ILCregs exert an inhibitory role in the innate immune response, favoring the resolution of intestinal inflammation.

Researchers found that ILCregs may be used to develop potential therapies to restore immune tolerance in chronic inflammatory and autoimmune diseases.


This research, entitled "Regulatory Innate Lymphoid Cells Control Innate Intestinal Inflammation," which was published in Cell on August 24, involved cooperation with the Institute of Biophysics (IBP), the Institute of Genetics and Developmental Biology, Sichuan University and Jinan University. Profs. FAN Zusen and WANG Shuo (IBP) are the corresponding authors. Drs. WANG Shuo and XIA Pengyan (IBP) are the co-first authors of this paper.

This work was supported by the National Natural Science Foundation of China, the Strategic Priority Research Programs of the Chinese Academy of Sciences, the Youth Innovation Promotion Association of CAS, and the China Postdoctoral Science Foundation.

Media Contact

FAN Zusen
[email protected]

Original Source

Leave A Reply

Your email address will not be published.